Ensign Peak Advisors
QTTB icon

Ensign Peak Advisors’s Q32 Bio QTTB Stock Holding History

Ensign Peak Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-64,481
Closed -$2.88M – 1733
2024
Q3 		$2.88M Hold
64,481
– – 0.01% 804
2024
Q2 		$1.16M Buy
64,481
+38,750
+151% +$927K ﹤0.01% 1193
2024
Q1 		$438K Buy
+25,731
New +$355K ﹤0.01% 1652
2022
Q2 		– Sell
-231
Closed -$13K – 2210
2022
Q1 		$13K Hold
231
– – ﹤0.01% 2187
2021
Q4 		$15K Buy
+231
New +$22.4K ﹤0.01% 2187
2020
Q4 		– Sell
-1,331
Closed -$256K – 1884
2020
Q3 		$256K Buy
+1,331
New +$298K ﹤0.01% 1645
2020
Q1 		– Sell
-719
Closed -$268K – 1690
2019
Q4 		$268K Buy
+719
New +$206K ﹤0.01% 1604

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ensign Peak Advisors's QTTB Position: Q4 2024 in Review

Ensign Peak Advisors sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 64,481 shares — an estimated $2.88M sold.

Ensign Peak Advisors first reported a position in QTTB in Q4 2019 and held it in 7 quarters. The position peaked at $2.88M in Q3 2024. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • Ensign Peak Advisors reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 64,481 Q32 Bio shares in Q4 2024, an estimated $2.88M.
  • Ensign Peak Advisors first reported a position in Q32 Bio in Q4 2019 and held it in 7 quarters.
  • Ensign Peak Advisors's Q32 Bio position peaked at $2.88M in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.